These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5152896)

  • 1. [Results of an immunodepressive treatment in La Peyronie's disease, Dupuytren's disease and certain sclerodermas].
    Sturm M; Lebeuf M
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(5):523-5. PubMed ID: 5152896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of Celestene by ionization in the treatment of rheumatic diseases].
    Aaron C; Quesnel MJ
    Sem Hop; 1978 Oct 18-25; 54(33-36):1091-4. PubMed ID: 220721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peyronie's disease and peripheral neuropathies].
    Diagne M; Gueye SM; Ba M; Konan PG; Diop AG; Ndiaye MM; Ndiaye IP; Mensah A
    Dakar Med; 1998; 43(2):234-7. PubMed ID: 10797972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of vascular allergids with Peyronie's and Dupuytren's disease. Favorable therapeutic effects of delta-butazolidine].
    TEODORESCO S; BADANOIU A
    Bull Soc Fr Dermatol Syphiligr; 1962; 69():295-300. PubMed ID: 13980590
    [No Abstract]   [Full Text] [Related]  

  • 5. Focused extracorporeal shockwave therapy in Dupuytren's disease--a hypothesis.
    Knobloch K; Kuehn M; Vogt PM
    Med Hypotheses; 2011 May; 76(5):635-7. PubMed ID: 21277691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
    Holzer LA; Holzer G
    Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ultrasonic treatment of Peyronie's disease.
    Frank IN; Scott WW
    J Urol; 1971 Dec; 106(6):83-7. PubMed ID: 5116297
    [No Abstract]   [Full Text] [Related]  

  • 8. Peyronie's disease and Dupuytren's contracture secondary to topical timolol.
    Oliphant H; Gouws P
    Int Ophthalmol; 2019 Mar; 39(3):683-685. PubMed ID: 29423783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natulan therapy in Dupuytren's contracture].
    Aron E
    Munch Med Wochenschr; 1971 Jul; 113(31):1079. PubMed ID: 5109396
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients with Dupuytren's Contracture, Ledderhose Disease, and Peyronie's Disease are at higher risk of arthrofibrosis following total knee arthroplasty.
    Wang CX; Flick TR; Patel AH; Sanchez F; Sherman WF
    Knee; 2021 Mar; 29():190-200. PubMed ID: 33640618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peyronie's disease associated with Dupuytren's contracture.
    WALLER JI; DREESE WC
    J Urol; 1952 Sep; 68(3):623-5. PubMed ID: 12991360
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)].
    Hasche-Klünder R
    Urologe A; 1978 Jul; 17(4):224-7. PubMed ID: 308273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of Dupuytren's disease with a cytostatic agent (methylhydrazine)].
    Aron E
    Presse Med (1893); 1968 Oct; 76(41):1956. PubMed ID: 5724620
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
    Riedl CR; Sternig P; Gallé G; Langmann F; Vcelar B; Vorauer K; Wagner A; Katinger H; Pflüger H
    Eur Urol; 2005 Oct; 48(4):656-61. PubMed ID: 15982798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A COLLAGEN TRIAD: LA PEYRONIE'S DISEASE, DUPUYTREN'S DISEASE AND FIBROSIS OF THE AURICULAR CARTILAGE].
    GALLIZIA F
    J Urol Nephrol (Paris); 1964 Jun; 70():424-7. PubMed ID: 14171347
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and cellular effects of colchicine in fibromatosis.
    Dominguez-Malagon HR; Alfeiran-Ruiz A; Chavarria-Xicotencatl P; Duran-Hernandez MS
    Cancer; 1992 May; 69(10):2478-83. PubMed ID: 1568169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peyronie's disease in systemic sclerosis.
    Ordi J; Selva A; Fonollosa V; Vilardell M; Jordana R; Tolosa C
    Ann Rheum Dis; 1990 Feb; 49(2):134-5. PubMed ID: 2317119
    [No Abstract]   [Full Text] [Related]  

  • 18. [Historical considerations on La Peyronie's disease. Very little has changed!].
    Jolidon C; Zephir D; Ybert G
    J Urol (Paris); 1984; 90(5):365-6. PubMed ID: 6389715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological characteristics of Peyronie's disease].
    Kapuller LL; Derevianko VP; Novak GIa; Bukhman AA
    Arkh Patol; 1982; 44(10):49-54. PubMed ID: 7181709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Sampaio FJ
    Int Braz J Urol; 2004; 30(4):349-50. PubMed ID: 15679983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.